Center for Structural Biology, Center for Cancer Research, National Cancer Institute, Frederick, MD, USA.
Biophysics Core Facility, National Heart, Lung, and Blood Institute, Bethesda, MD, USA.
FEBS J. 2023 Feb;290(3):780-795. doi: 10.1111/febs.16635. Epub 2022 Oct 6.
l-asparaginases from mesophilic bacteria (ASNases), including two enzymes very successfully used in the treatment of leukaemia, have been consistently described as homotetramers. On the contrary, structural studies show that homodimers of these enzymes should be sufficient to carry out the catalytic reaction. In this report, we investigated whether the type I Yersinia pestis asparaginase (YpAI) is active in a dimeric form or whether the tetrameric quaternary structure is critical for its activity. Using multiple biophysical techniques that investigate enzymatic properties and quaternary structure at either high or low protein concentration, we found that dimeric YpAI is fully active, suggesting that the tetrameric form of this subfamily of enzymes does not bear significant enzymatic relevance. In this process, we extensively characterized YpAI, showing that it is a cooperative enzyme, although the mechanism of allostery is still not definitely established. We showed that, like most type I ASNases, the substrate affinity of YpAI is low and this enzyme is very similar in terms of both the structure and enzymatic properties to homologous type I ASNase from Escherichia coli (EcAI). We extended these studies to more medically relevant type II ASNases, used as anti-leukaemia drugs. We confirmed that type II ASNases are not allosteric, and that they might also be functional in a dimeric form. However, the determination of the accurate tetramer⇆dimer dissociation constants of these enzymes that most likely lie in the picomolar range is not possible with currently available biophysical techniques.
来自嗜温细菌的 l-天冬酰胺酶(ASNases),包括两种在治疗白血病方面非常成功的酶,一直被描述为同三聚体。相反,结构研究表明,这些酶的同源二聚体足以进行催化反应。在本报告中,我们研究了肠鼠疫耶尔森氏菌天冬酰胺酶(YpAI)是否以二聚体形式发挥活性,或者四聚体四级结构对其活性是否至关重要。我们使用多种生物物理技术研究酶的性质和在高或低蛋白质浓度下的四级结构,发现二聚体 YpAI 具有完全活性,这表明该酶亚家族的四聚体形式对酶活性没有显著影响。在此过程中,我们对 YpAI 进行了广泛的表征,表明它是一种协同酶,尽管变构作用的机制尚未明确确定。我们表明,与大多数 I 型 ASNases 一样,YpAI 的底物亲和力较低,并且在结构和酶性质方面与大肠杆菌(EcAI)的同源 I 型 ASNase 非常相似。我们将这些研究扩展到更具医学相关性的 II 型 ASNases,它们被用作抗白血病药物。我们证实 II 型 ASNases 不是变构的,它们也可能以二聚体形式发挥功能。然而,由于目前可用的生物物理技术,无法确定这些酶的准确的四聚体⇆二聚体解离常数,这些酶的解离常数很可能处于皮摩尔范围内。